Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.
Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.
Seralite® – FLC Serum
Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.Read More
A recent study used Abingdon Health’s Seralite®-FLC #ELISA to assess the impact of long duration spaceflight on ast… https://t.co/aITphdnAqP
22 June 2018
© Abingdon Health 2018